Dentatorubral-Pallidoluysian Atrophy (DRPLA)
A rare inherited disorder affecting movement, thinking, and seizures
Quick Facts
- Type: Inherited neurodegenerative disorder
- Inheritance: Autosomal dominant
- Main features: Ataxia, involuntary movements, seizures, decline
- Onset: Childhood or adulthood, varying by age
Overview
Dentatorubral-pallidoluysian atrophy, usually shortened to DRPLA, is a rare inherited disorder that causes progressive degeneration of specific parts of the brain involved in movement, coordination, and thinking. Its long name comes from the brain regions most affected. Over time, the loss of nerve cells in these areas leads to a combination of neurological problems that gradually worsen.
DRPLA belongs to a group of inherited conditions caused by an expanded, repeated section of DNA in a particular gene. It is more common in some populations than others and is rare overall. The pattern of symptoms depends heavily on the age at which the condition begins: children tend to have seizures and developmental difficulties, while adults more often have coordination problems and involuntary movements. There is currently no cure, so care focuses on managing symptoms and supporting quality of life.
Symptoms
The symptoms of DRPLA vary with the age of onset and tend to progress over time. They can include:
- Ataxia, with poor balance, unsteady walking, and clumsiness
- Involuntary movements, such as jerky (chorea) or sudden muscle jerks (myoclonus)
- Seizures, which are especially common when the condition begins in childhood
- Decline in memory, thinking, and behavior over time
- Changes in mood or personality
- Slurred speech and difficulty with coordination of movement
In children and young people, seizures, behavioral changes, and learning difficulties are often prominent, while in adults, ataxia and involuntary movements tend to dominate. The condition is progressive, meaning symptoms gradually worsen.
Causes
DRPLA is caused by a specific genetic change.
- Gene expansion: The condition results from an abnormally expanded section of repeated DNA in a particular gene, which leads to the gradual loss of nerve cells in affected brain regions.
- Autosomal dominant inheritance: Only one altered copy of the gene is needed to cause the condition, so it can be passed from an affected parent to a child.
- Anticipation: In some families, the condition tends to begin earlier and be more severe in successive generations as the repeated section grows.
The condition is not caused by lifestyle or environment; it is a genetic disorder present from birth, even if symptoms appear later.
Risk Factors
- Having a parent or close relative with DRPLA
- Inheriting the expanded gene from an affected parent
- Ancestry from populations where the condition is more common
Diagnosis
Diagnosis combines the clinical picture, family history, and genetic confirmation.
- Neurological examination: Assessing coordination, movements, seizures, and cognitive function.
- Family history: The autosomal dominant pattern often shows affected relatives across generations.
- Brain imaging: MRI may show shrinkage in affected brain regions.
- Genetic testing: The definitive test, which detects the expanded section of DNA in the responsible gene.
Because the symptoms overlap with other inherited neurological conditions, genetic testing is key to confirming the diagnosis. Genetic counseling is usually offered to the person and their family.
Treatment & Management
There is currently no cure or treatment that stops the progression of DRPLA, so care focuses on managing symptoms and supporting the person and family.
- Seizure control: Medications to manage seizures, which are common in early-onset disease.
- Managing movements: Medicines may help reduce troublesome involuntary movements.
- Physical, occupational, and speech therapy: To support mobility, daily function, communication, and safety.
- Cognitive and behavioral support: Help for memory, thinking, and behavior changes.
- Supportive and palliative care: Coordinated care over time to maintain comfort and quality of life.
- Genetic counseling: For the person and family to understand inheritance and options.
A team approach involving neurology and other specialists helps address the wide range of symptoms.
Self-Care & Prevention
- DRPLA is inherited and cannot be prevented, but symptoms can be managed
- Take medications as prescribed, especially for seizures
- Stay engaged with therapy to maintain function and safety
- Make the home safer to reduce the risk of falls and seizure-related injury
- Seek genetic counseling for family planning if there is a family history
When to See a Doctor
See a doctor if you or your child develops unexplained, progressive problems with coordination, balance, involuntary movements, seizures, or changes in memory and behavior, particularly if there is a family history of a similar condition. Seek emergency care for:
- A first-time seizure, or a seizure lasting more than five minutes or one seizure following another without recovery in between
- A serious injury during a seizure or fall
- Sudden, severe neurological symptoms
Frequently Asked Questions
What is DRPLA?
DRPLA, or dentatorubral-pallidoluysian atrophy, is a rare inherited disorder that gradually damages specific parts of the brain involved in movement and thinking. It causes a combination of ataxia, involuntary movements, seizures, and cognitive decline that worsens over time.
How is DRPLA inherited?
DRPLA is inherited in an autosomal dominant pattern, meaning only one altered copy of the gene is needed to cause it, and it can be passed from an affected parent to a child. It is caused by an expanded, repeated section of DNA in a particular gene.
Why do symptoms differ between children and adults?
The pattern of symptoms depends on the age at which the condition begins. Children more often have seizures, learning difficulties, and behavioral changes, while adults more often have ataxia and involuntary movements. The size of the gene expansion influences the age of onset and severity.
Is there a cure for DRPLA?
There is currently no cure or treatment that stops the disease from progressing. Care focuses on managing symptoms, such as controlling seizures and movements, supporting mobility and thinking with therapy, and providing supportive care to maintain quality of life.
Should family members consider testing?
Genetic counseling is usually recommended when there is a family history, to explain the inheritance pattern, the chance of family members being affected, and options for testing and family planning. Decisions about testing are personal and best made with guidance from a genetics professional.
References
- National Institute of Neurological Disorders and Stroke (NINDS). Ataxia and inherited neurological disorders.
- MedlinePlus, U.S. National Library of Medicine. Dentatorubral-pallidoluysian atrophy.
- National Ataxia Foundation. About ataxia.
- Genetic and Rare Diseases Information Center (GARD).